Target intelligence / Profile preview

Novel transcript, antisense to DCHS2 (ENSG00000280005)

Target
ENSG00000280005
Molecular classification
Other (Antisense non-coding RNA)
01

Overview

ENSG00000280005 represents an **antisense non-coding RNA transcript** overlapping or adjacent to the **DCHS2 locus**. Antisense transcripts are RNA molecules that are complementary to the sense mRNA of a gene and can influence gene expression through various mechanisms, including transcriptional interference, chromatin modification, and regulation of RNA stability[1][3]. There is a conserved biological effect of antisense transcription in altering the chromatin landscape near gene promoters and regulating the dynamics of sense RNA production, processing, and degradation[1][3]. However, specific molecular or physiological functions of this transcript in humans are not defined, and it is not recognized as a therapeutic or pharmacological target within current literature or drug databases. There is no evidence this transcript encodes a protein or has receptor/enzyme/transporter activity. In summary: ENSG00000280005 is a novel antisense non-coding RNA transcript to DCHS2, not a standard drug target or receptor, with insufficient data regarding functional, disease, or pharmacological roles[1][3].

02

Biological functions

Regulation of sense transcriptionChromatin modulationOther (antagonistic modulation of DCHS2 expression, possible involvement in epigenetic regulation)

Beyond the preview

Go deeper on Novel transcript, antisense to DCHS2 (ENSG00000280005).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to DCHS2 (ENSG00000280005).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call